Join us as we speak to Dr. Benjamin Lampson of Dana-Farber Cancer Institute in Boston, MA. In Part One of this two-part series on mantle cell lymphoma (MCL), Dr. Lampson discusses the latest treatment advances for MCL. With more treatments available than just a few years ago, Dr. Lampson shares how his conversations with his patients have changed, providing more hope after a diagnosis of MCL.

Be sure to tune into Part 2 launching on May 23, 2022, where Dr. Lampson will focus on the exciting possibilities of CAR T-cell therapy for MCL.

Mentioned on this episode: 

• Mantle Cell Lymphoma
• Mantle Cell Mantle Cell Lymphoma (MCL) with Dr. Benjamin Lampson: What Patients Should Know episode
• LLS COVID Antibody Study and COVID resources
• Protecting Patients: COVID and Vaccine Updates episode
• Stem Cell Transplant
• Autologous Stem Cell Transplant
• Allogeneic Stem Cell Transplant
• Graft-vs-Host Disease
• Highlights from ASH conference

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Free booklets 
• LLS Public Policy & Advocacy
• Clinical Trial Support Center
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy
• Survivorship Workbook

Support for this episode provided by Eli Lilly & Company.

The post Mantle Cell Lymphoma (MCL) Part One: Treatment Advances appeared first on The Bloodline with LLS.